Wasan Cartwright
Family · Albuquerque, NMNPI 1073123063
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,870, more than ten times the $40 reported in 2021. Among family clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $25.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$996
- Sanofi$490
- Regeneron Healthcare Solutions, Inc.$476
- Genentech USA, Inc.$356
- CSL Behring$312
- Grifols USA, LLC$244
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,31299%
- Education$641%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $996 |
| Sanofi | 22 | $490 |
| Regeneron Healthcare Solutions, Inc. | 20 | $476 |
| Genentech USA, Inc. | 13 | $356 |
| CSL Behring | 12 | $312 |
| Grifols USA, LLC | 14 | $244 |
| Incyte Corporation | 13 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $222 |
| Novartis | 8 | $200 |
| Amgen | 7 | $169 |
| GSK | 7 | $161 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $129 |
| Biocryst US Sales Co., LLC | 5 | $99 |
| Aerin Medical Inc. | 3 | $52 |
| Indivior Inc. | 3 | $50 |
| Alkermes, Inc. | 3 | $49 |
| Blueprint Medicines Corporation | 2 | $46 |
| Biogen | 1 | $25 |
| Viatris Specialty LLC | 1 | $21 |
| LEO Pharma Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,376 in reported general payments places this provider in the 95th percentile of 1,080 family providers in New Mexico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SymbicortBudesonide/Formoterol Fumarate | 26 | $7,512 |
| Epinephrine | 31 | $7,507 |
| Qvar RedihalerBeclomethasone Dipropionate | 20 | $6,102 |
| Ipratropium Bromide | 178 | $5,604 |
| Arnuity ElliptaFluticasone Furoate | 21 | $4,030 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,733 |
| Azelastine Hcl | 40 | $1,145 |
| Fluticasone Propionate | 34 | $564 |
| Montelukast Sodium | 22 | $390 |
| Prednisone | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaSymbicort | $996 | $7,51226 claims |
| GSKArnuity Ellipta | $161 | $4,03021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,080 family providers in New Mexico.
Other family in Albuquerque
- Barbara FranklinAlbuquerque$28K
- Melanie DuranAlbuquerque$15K
- Irasema LlewellynAlbuquerque$14K
- Charles GallegosAlbuquerque$10K
- Marlyn NewbyAlbuquerque$9K
- Annmarie FoleyAlbuquerque$8K
- Aimee CasarezAlbuquerque$7K
- Rita SuharliAlbuquerque$6K
- Matthew TotterAlbuquerque$6K
- Roberta ChampouillonAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.